PARP1 and head and neck squamous cell carcinoma: Another strategy proposed for the treatment of HNSCC is the inhibition of PARP1, which plays a key role in the cellular response to DNA damage and replication stress, including through protein paralysis, replication fork stabilization, and interaction with p53.